Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
701 (USA) · Dr. Reyes
consented 2014-01-25
Adverse events
Mild APPLICATION SITE ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-03-09 (study day 44.0); relationship: PROBABLE
Mild APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-02-22 (study day 29.0); relationship: POSSIBLE
Mild RHINORRHOEA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-07-09 (study day 166.0); relationship: NONE
Mild RHINORRHOEA — outcome: RECOVERED/RESOLVED; onset 2014-07-09 (study day 166.0); relationship: NONE
Mild SALIVARY HYPERSECRETION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-26 (study day 2.0); relationship: NONE
Data queries
No data queries.